65 results
Pathophysiology Euglycemic DKA - Mechanism of SGLT-2 Inhibitors #Pathophys #Endocrine #Euglycemic #DKA #SGLT2 #Mechanism
Pathophysiology Euglycemic ... Pathophys #Endocrine #Euglycemic ... #DKA #SGLT2 #Mechanism
SGLT2 Inhibitors and Euglycemic DKA

Risk factors for euglycemic DKA in those on an SGLT2i include:
 •
SGLT2 Inhibitors ... and Euglycemic ... Risk factors for euglycemic ... is closed • SGLT2 ... #Euglycemic #DKA
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... Ketoacidosis (EuDKA) SGLT2 ... @accpcardprn #Euglycemic
Metabolic Acidosis with Anion Gap - KILU Mnemonic

K - Ketoacidosis
	• DKA
		- With normal glucose, ask if
glucose, ask if on SGLT2 ... - Eugylcyemic ... ketoacidosis in SGLT2 ... inhibitors and SGLT2
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... Action: Inhibits SGLT2 ... candidiasis) • Euglycemic ... EricsMedicalLectures/featured #SGLT2
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
Trials - EGDT: NEJM ... - ProCESS: NEJM ... 2014 - ARISE: NEJM ... - ProMlSe: NEJM ... Therapy #Trials #EBM
PCI in Acute MI with Cardiogenic Shock. #EBM #Cardiology #CULPRITSHOCK #PCI #VisualAbstract #NEJM
#EBM #Cardiology ... VisualAbstract #NEJM
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Episodic Migraine #EBM ... VisualAbstract #NEJM
Trial of Solanezumab for Mild Dementia Due to Alzheimers Disease #EBM #Dementia #Solanezumab #Alzheimers #NegativeTrial #VisualAbstract
Alzheimers Disease #EBM ... VisualAbstract #NEJM
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment #EBM #Hepatology #HCV #CKD #Glecaprevir
Renal Impairment #EBM ... VisualAbstract #NEJM